Landauer — Q3 2015 Earnings Presentation
24 slides from Landauer's earnings presentation, Aug 11, 2015
Slide 1: Investor Presentation August 2015
I nvestor Presentation August 2015
Slide 2: Safe Harbor Statement
Safe Harbor Statement Some of the information shared here (including, in particular, the section titled “Fiscal 2015 Outlook”) constitutes forward-looking statements that are based on assumptions and involve certain risks and uncertainties. These include the following, without limitation: assumption
Slide 3: Compelling Investment Opportunity
Compelling Investment Opportunity Industry leading position, compelling market trends and strong financial profile drives long-term shareholder value •The Joint Commission standards effective in July 2015 in the United States -Impacts 7,100 of the 20,500 U.S. healthcare organizations and programs, i
Slide 4: Leading OSL Technology Supported by Proven Process
Dosimetry Reports with results are made available to the customer Leading OSL Technology Supported by Proven Process .“Gold standard” in accuracy .Proprietary OSL crystal technology manufactured internally .Delivers wide-range of radiation monitoring: .Headquartered in Glenwood, IL .650 global emplo
Slide 5: Serving Diverse End Markets Across Three Verticals
$40 $24 $91 Industrial ProfessionalOffices Acute CareHospitals $0 $20 $40 $60 $80 $100 $MM Revenue Serving Diverse End Markets Across Three Verticals Acute Care Hospitals Professional Offices Industrial Energy Emergency Response Military/ National Security/DOE W:\Landauer\Investors\Investor deck\Ima
Slide 6: Strong Global Footprint
Strong Global Footprint Well-positioned to serve an expanding global customer base of ~75,000 clients Service Labs Chicago Mexico Brazil Paris Istanbul Beijing Tokyo Australia
Slide 7: Significant International Growth Opportunity
Significant International Growth Opportunity $25 $30 $35 $40 2011 2012 2013 2014 $MM International Revenue Constant $ GAAP International Revenue 76% 24% FY GAAP 2014 Revenue Domestic U.S. International Additional $2.9 million in Equity Income from International Joint Ventures Joint Venture Location
Slide 8: U.S. Healthcare Trends are Fueling Opportunity
U.S. Healthcare Trends are Fueling Opportunity Increasingly complex and multi-dimensional radiation management landscape creates need for integrated, enterprise-wide solutions Risk to Health Systems Tougher State Regulations Emerging •Pennsylvania •California •Massachusetts •Rhode Island •Texas Heal
Slide 9: Uniquely Positioned to Capitalize on Demand for Solutions
Reports: Necessary for compliance Analytics: Context to information Benchmarking: Relevance to peers Training: Assures compliance and patient outcomes Continuous Improvement: Integrated data across the enterprise Uniquely Positioned to Capitalize on Demand for Solutions Combining products, services,
Slide 10: Strategic Path Forward
Strategic Path Forward .Shift the market focus .Simple dose focus .Continuous management of radiation safety .Better equip customers to monitor and control employee exposure and meet increasing compliance regulations .Leverage digital-based platform to grow offering of tailored products and services
Slide 11: Verifii: Redefining Our Core Technology
Verifii™: Redefining Our Core Technology .Provides customers with a scalable, digital platform that connects employees to their environment .Eliminates fragmented manual processes enabling focus on building a robust radiation management solution .Timely radiation data adds value to customers by allo
Slide 12: Creating a New Standard with Digital Dosimetry
Creating a New Standard with Digital Dosimetry Real-time and historic data & analytics are available to client via web & mobile apps Data is processed and stored in the cloud Dosimeter connects via Bluetooth LE to docking base station Dosimeter is assigned to individual onsite; establishing chain of
Slide 13: Significant Opportunities Across Core Verticals
Significant Opportunities Across Core Verticals .Virtual compliance solution for smaller offices that do not have an existing function in place .340,000 sites across Veterinarians, Medical, Dental and Chiropractic practices .6% estimated U.S. market share .Increasing regulations and use of advanced
Slide 14: Strong Recurring Revenue Base
Strong Recurring Revenue Base $114 (95%) $138 (91%) $136 (91%) $137 (88%) $6 $14 $14 $18 $0 $20 $40 $60 $80 $100 $120 $140 $160 $180 2011 2012 2013 2014 Revenue ($ in millions, FYE 9/30) Recurring Revenue Non-Recurring Revenue $120 $152 $150 $155
Slide 15: Driving Strong Cash Flows
.New IT systems implemented in FY12 negatively impacted working capital in FY13 by $11.0 million and positively impacted working capital in FY14 by $10.6 million .System implementation impacted timing of customer collections and vendor payments Driving Strong Cash Flows $18.3 $21.9 $16.2 $32.5 $0.0
Slide 16: Balanced Approach to Capital Allocation
Balanced Approach to Capital Allocation .Core business investments focused on top and bottom line growth .Emphasis on higher margin, annuity-style opportunities .Commercialization of next generation digital dosimetry platform while transitioning from current OSL crystal-based platform .Management co
Slide 17: Compelling Investment Opportunity
Compelling Investment Opportunity Industry leading position, compelling market trends and strong financial profile drives long-term shareholder value •The Joint Commission standards effective in July 2015 in the United States -Impacts 7,100 of the 20,500 U.S. healthcare organizations and programs, i
Slide 18: Financial Overview
Financial Overview
Slide 19: Landauer Financial Overview
Landauer Financial Overview $120.5 $152.1 $149.7 $155.1 2011 2012 2013 2014 Revenue ($ in millions, FYE 9/30) $48.2 $54.0 $47.9 $44.4 2011 2012 2013 2014 Adjusted EBITDA ($ in millions, FYE 9/30) .Approximately 90% of revenue derived from subscriptions and is recurring in nature .Increase operating
Slide 20: Key Q3 FY 2015 Financial Drivers
Key Q3 FY 2015 Financial Drivers .Revenue of $35.5 million in the third quarter of fiscal 2015 down $0.4 million y/y due to unfavorable FX .Domestic Radiation Measurement revenues grew by 1.5% over the prior year period .Medical Physics revenues grew 8.5% over the prior year period, driven by demand
Slide 21: Q3 2015 YTD Adjusted Results
Q3 2015 YTD Adjusted Results ($ Millions) Q3 YTD As Reported Non-cash Stock Based Compensation Q3 YTD Adjusted Revenue $111.2 - $111.2 Net Income $12.0 $1.1 $13.1 Adjusted EBITDA $27.2 $1.4 $28.6
Slide 22: Underlying Assumptions for 2015
Underlying Assumptions for 2015 .As communicated in our previous earnings release, due to the impact of unfavorable foreign currency rates, we expected results for FY2015 near the lower end of the range .We expect the adverse impact of FX to reduce y/y revenue by $6.0 million, Adjusted Net Income by
Slide 23: Appendix
Appendix
Slide 24: Landauer at a Glance
Business Facts Proven Technology Platform Fiscal 2014 Financial Highlights Diverse Markets .$155 Million in Annual Revenue .$37 Million in International Sales .~ 90% Recurring Revenues .$44.4 Million in Adjusted EBITDA .Adjusted EBITDA margin 28.6% .Headquartered in Glenwood, IL .Founded in 1954 .Ap